Suzhou New District and aap Implantate AG sign a contract to establish an R&D headquarters on March 3. [Photo/snd.gov.cn]
German medical implant manufacturer aap Implantate AG signed a contract with Suzhou New District on March 3 to establish a research and development and production headquarters in SND.
The aap Implantate AG China R&D and production headquarters will establish a team and R&D testing laboratory in the fourth phase of the Jiangsu Medical Device Technology Industrial Park, conduct clinical trials on high-end silver ion anti-infection implants, and fill the domestic gap in related fields.
Founded in Berlin, Germany, aap Implantate AG is listed on the Frankfurt Stock Exchange. Its products have a high market share and strong reputation in Europe and the United States, with patented high-end silver ion anti-infection coating technology that can effectively reduce the infection rate of orthopedic implants after surgery.
In October 2022, USM Healthcare Technology (Suzhou) Co, a company in SND, became the largest shareholder of aap Implantate AG.
Rubino Di Girolamo, CEO of aap Implantate AG, stated that the establishment of the China R&D and production headquarters in Suzhou is an important strategic measure in which aap Implantate AG will help to develop the Chinese market, and the favorable business environment, efficient government services, and beautiful natural environment of SND make it the company's best choice.
In recent years, SND has made every effort to strengthen the high-end medical device industry innovation cluster, with more than 900 related enterprises gathered in the field of high-end medical devices, and an annual average growth rate of industrial output value exceeding 30 percent.
